Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial Assessing the Efficacy and Safety of Grazax in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma

NCT00421655 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT00421655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial Assessing the Efficacy and Safety of Grazax in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma
Lead sponsor
ALK-Abelló A/S
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
October 31, 2007
Enrollment
329 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy